Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
AB 260 would protect access to medication abortion and shield providers in California amid federal uncertainty
Summary
AB 260 (labeled AB 2 60 in testimony) would protect access to mifepristone and other medication‑abortion services in California, shield clinicians and pharmacists from disciplinary action for providing medication abortion, allow removal of provider names from prescription labels, and expand telehealth access for medication abortion.
Majority Leader presented AB 260 as a measure to "protect safe and legal reproductive health care here in California," emphasizing concern about recent federal actions that could limit access to medication abortion. The bill specifically targets statutory protections for the medication mifepristone, shielding clinicians and pharmacists from licensing or disciplinary penalties when they legally provide the medication, enabling certain privacy protections for prescribers, requiring continued health‑plan coverage for medication abortion, and expanding telehealth access.
Dr. Kelly Pfeiffer, a family medicine physician who runs…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
